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Nitric Oxide Synthase Encapsulation in Liposomes: a Potential
Delivery Platform to (Nitric Oxide)-Deficient Targets
Reshani H. Perera, Pubudu M. Peiris, Serban F. Peteu, Mekki Bayachou
Abstract
Nitric oxide (NO) is a freely diffusible, gaseous free radical, associated with many physiological and pathological
processes: such as neuronal signaling, immune response and inflammatory response. In mammalian organisms, NO
is produced from l arginine in an NADPH dependent reaction catalyzed by a family of nitric oxide synthase (NOS)
enzymes. Typically, large NO fluctuations in biological systems under/over a critical limit is associated with problems
that range from transient dysfunctions to severe chronic disease states. In this regard, we explore the development
of a potential delivery and release method of nitric oxide to NO deficient sites using liposomes as vehicles. Lipo
somes have already been used as effective nano carriers. In this short communication, we report on the preparation
and characterization of liposomes carrying a recombinant NOS enzyme. We report on the efficacy of using lipo
somes to carry NOS enzymes, and on the extent of preservation of native NOS structure and function. In addition
to the characterization of liposome stability and recovery of enzymatic activity after encapsulation in liposomes, we
also measured the NO production upon NOS stimulation. The NO release was monitored with a nitric oxide ultra
sensitive electrochemical microsensor placed near NOS carrying liposomes. This method of NOS carrying liposomes
shows the promise of potential development as a platform for targeted NO delivery.
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After being recognized, 20 years ago, as the endothelium-
derived relaxing factor in the vascular system [1], nitric
oxide (NO) has been subsequently identified as a neuro-
transmitter, neuro-modulator [2] and a cytotoxic factor in
the immune system [3,4]. Moreover, a number of studies
have revealed a role for NO in producing tissue damage,
such as ischemia/reperfusion injury [3,5] or excitatory
neuronal death [6–8].
NO is produced from the guanidino group of l-arginine
in an NADPH-dependent reaction, catalyzed by a family
of nitric oxide synthase (NOS) enzymes [9]. Given NO
involvement in numerous vital processes, a critical change
in its physiological concentration can harm biological sys-
tems. For instance, lower than normal NO levels could
lead to hypertension [10,11], impotence [12,13], hypergly-
cemia, and arteriosclerosis [14,15], to cite a few.
However, a direct release of NO doses to biological tar-
gets has clinical limitations, due to both its relative short
lifetime and high reactivity [16]. In this regard, in situ
transport and delivery of NO-releasing sources such as
NO-making enzymes (NOSs) represent potential alterna-
tives. In a related aspect, the NOS gene transfer has been
already reported as a potential approach to counteract
NO deficiency [16–18]. Even though the NOS gene thera-
py has some therapeutic benefits, there are several obsta-
cles to advance clinical practice. The foremost concerns
of NOS gene therapy are the limitations of currently
available vectors, the need of targeted delivery methods,
and the relative difficulties to control the in situ NOS ex-
pression.
By contrast, the targeted delivery of NOS enzymes is
an important approach to explore. In this regard, carrying
vectors such as liposomes are effective delivery systems,
able to shuttle molecules to sites of action. Once at a cell
site, the liposome lipid bilayer can fuse with the cell
membrane bilayer, thereby releasing its contents. The ad-
vantages of using liposomes carrying target proteins in-
clude the stabilization, prevention of denaturation, or
proteolysis of the protein. Consequently, the liposome-en-
trapped NOS could be safely ferried and released to pre-
ordered sites that can potentially be targeted using chemi-
cal groups on the surface of the liposomes.
One aim of this study is to investigate the effectiveness
of the NOS liposomal transport, and to evaluate the pro-
tection of NOS native structure and function within the
liposomal microenvironment for potential NO delivery to
medically significant targets. Issues of targeted delivery to
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rored the instability in terms of size as described in the
previous section.
% NOS activity in liposomes. The Griess assay is com-
monly used to measure NO synthesis from NOS [20,21].
This assay quantifies the nitrite as the breakdown product
of NO [22]. Appropriate controls with blanks containing
all components except the NOS enzymes are part of the
calibration curve construction process. The assay was
used here to determine NOS activity in liposomes in com-
parison to NOS activity prior to encapsulation. The
Griess assay measurements on our NOS-liposome prepa-
rations show that the percentage of the activity inside the
liposomes is ~76% (n=3) of the initial NOS activity.
This relatively high % activity value demonstrates the re-
taining of the NOS activity inside the vesicles.
Measurement of Nitric Oxide release from NOS in lipo-
somes. We used our proprietary NO-sensitive electro-
chemical ruthenium-modified carbon microfiber sensor
[23] in order to monitor nitric oxide dynamically released
from single NOS-loaded liposomes upon NOS chemical
stimulation. Details about the fabrication of the NO-
sensor are in the included in the experimental section.
The NOS-loaded liposomes were incubated with a PBS
buffer solution. A micromanipulator attached to the stage
of an inverted microscope allowed the positioning of the
NO-selective microsensor 101 mm above the liposome
surface. A potential of +0.5 V vs. Ag/AgCl was applied
to the NO microsensor. Once a steady background cur-
rent is obtained, an aliquot of 150 mM of NADPH was in-
jected 101 mm away from the isolated single liposome
surface to stimulate NO release. NO is then measured as
an oxidation current on the NO-sensor.
A typical chronoamperometric dose-response curve in
the form of a calibration plot for our NO-sensor is shown
in Figure 2.
The amperometric response of the NO microsensor
upon subsequent additions of NADPH and blank PBS
buffer solution as a control to the NOS-loaded liposomes
preparation is illustrated in Figure 3.
The stimulation of NO synthesis, upon injection of
NADPH in the vicinity of a single liposome using micro-
manipulators on an inverted microscope stage, generated
a flux of NO that is released and detected at the nearby
NO-sensitive microfiber, in the form of a change in cur-
rent signal as a function of time (Figure 3A). All electro-
chemical measurements are performed on fresh prepara-
tion of liposomes (1–2 days). The sharp drop in current
signal after the injection of 45 nmol of NADPH is due to
the oxidation of the NO released from a single NOS-car-
rying liposome, isolated in a dilute liposome preparation.
Control experiments with the addition of 10 mL of buffer
solution to NOS-liposomes did not give the response ob-
served with NADPH. Also, as shown in Figure 3B, lipo-
somes with NOS treated l-N-nitroarginine methyl ester
(l-NAME), a known potent NOS-inhibitor, do not give
the typical responses reflecting full activity. Also, injec-
tion of NADPH in the bulk of the solution did not yield
the typical oxidation peaks observed when the microsen-
sor is placed near NOS-carrying liposomes (Figure 3C).
The pulsed nitric oxide concentration profile released
from each NOS-loaded liposome peaks at about
~19.8 nM. Using a spherical diffusion model, we calculat-
ed the amount of NO released from one liposome to be
around ~3.7 amol. This value remains relatively constant
from one NOS-loaded liposome to another as long as the
size does not change.
Conclusions. Overall, we show that NOS encapsulation
in DSPC liposomes is achieved using the thin-film hydra-
tion method in the presence of NOS enzyme in the hyd-
rating solution. A suspension of monodisperse NOS-con-
taining vesicles is prepared using an extrusion process
through a 100-nm pore size membrane. Protein assay
measurements show that the method as described ach-
ieves relatively high encapsulation efficiency of about
4025%. Size monitoring using DLS shows excellent sta-
bility of NOS-loaded liposomes during storage for at least
15 days, during which the NOS-enzymatic activity is also
retained. Measurement of enzymatic activity shows that
the percentage of the activity inside the liposomes is
~75% of the initial NOS activity. Electrochemical mea-
surement of NO released from single NOS-loaded lipo-
somes indicates that the amount of NO released from
one liposome in the preparation as described is around
~3.7 amol. Together, these results show that NOS encap-
sulation in DSPC liposomes is a viable approach for the
delivery of active NOS enzymes to targeted sites. Work is
now in progress to investigate the use and efficiency of
Fig. 2. Typical NO microsensor calibration plot.
Table 1. Values obtained from Bradford assay. NOS*: input con
centration after subtracting unloaded NOS.
Sample [Enzyme] (mg/mL)
NOS* 8.02.3
Intact NOS loaded Liposome ~0.00
Disrupted NOS liposome 3.02.1
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The recombinant iNOS proteins used in this work were
overexpressed in the E. coli strain BL21 (DE3) using a
pCWori vector and purified as reported in the literature
[25]. The plasmid was a kind gift from Dr. Stuehrs labs
(Lerner Research Institute, Cleveland Clinic).
The dry, thin, lipid film was further dried, by flowing
dry N2 gas into the flask and ensure complete evaporation
of the organic solvent. An aqueous solution of the iNOS
enzyme of 0.45 mM concentration was then used to hy-
drate the lipid film before dilution with a pH 7.4 buffer
solution. In order to eliminate non-encapsulated protein,
the liposome suspension was passed through a Ni2+
column, which traps only the free histidine-tagged iNOS
proteins. The fractions containing NOS-carrying lipo-
somes were collected and used for further analysis.
The liposome average diameter and size distribution of
the vesicles were determined by the dynamic light scatter-
ing (DLS). A 20 mL aliquot of the liposome dispersion
was diluted with 1 ml of filtered buffer solution (0.2 mm
pore size polycarbonate filters) and measurements were
made at 25 8C. The stability of the liposome dispersion
upon storage at 4 8C was monitored periodically by DLS.
The Griess assay reagent kit was used with the instruc-
tion provided. Briefly, the NADPH-treated 100 mL of
sample was incubated with 100 mL of sulfanilamide for
10 minutes in the dark followed by 10-minute reaction
with 100 mL N-1-napthylethylenediamine dihydrochloride
(NAD) in the dark at room temperature. The absorbance
was recorded at 540 nm. A calibration curve was con-
structed using known concentration series of NO in
buffer conditions similar to our liposomal preparations.
The enzyme activity of NOS-carrying liposomes was
determined via the detection of NO, released when stimu-
lated by NADPH, with our Ru-PEDOT modified carbon
fiber electrode (CFE) NO-sensitive microsensor. All elec-
trochemical measurement of NO synthesis from NOS-
carying liposomes is performed on freshly prepared NOS-
liposomes (1–2 days). Experimental details about the
NO-sensor are found elsewhere [23] as well as in other
reports about other CFE microsensors developed in our
labs [26]. Briefly, this NO microsensor was fabricated as
follows. A single carbon fiber (7 mm diameter) was
mounted on the end of a copper wire using conductive
epoxy, then inserted into the glass capillary and sealed.
The carbon fiber was cut leaving a protruding portion of
about to 3 mm. All potentials reported here are versus a
Ag/AgCl reference electrode. A platinum wire was used
as the auxiliary electrode. The polymerization of 3,4-eth-
ylenedioxythiophene (EDOT) monomer was done in a
three-electrode electrochemical cell, to provide the
matrix on which the catalytic ruthenium nanoparticles
used in NO sensing are deposited. The ruthenium nano-
particles are then deposited from a RuCl3 solution in
perchloric acid.
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